FDA Approves Supplemental Application for Capecitabine by Accord Healthcare
The FDA has approved a supplemental application for Capecitabine submitted by Accord Healthcare.
Asset / Drug
Drug and asset intelligence for Capecitabine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.